A clinical trial involving pramlintide has been updated as of June 9, 2026. The study, titled "Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide," is registered under identifier NCT06422325. Its status is listed as completed. The trial phase is listed as not applicable.
The study design is a two way crossover, comparing a closed loop insulin regimen against a closed loop regimen that includes insulin and pramlintide together. No results have been reported alongside this status update. The available data indicate only the change in trial status, not any outcomes or findings.
Pramlintide is an approved compound, and this trial update reflects its use in an investigational closed loop insulin study context. Readers should note that a completed status means the study has concluded data collection or the trial period, but it does not by itself indicate what, if any, results were observed.
Further detail on trial outcomes, if and when posted, would appear in future updates to this same registry entry. For more background on pramlintide, see the compound overview.